Literature DB >> 22248146

Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.

Jamie D Croxtall1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248146     DOI: 10.2165/11208310-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  23 in total

1.  Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation.

Authors:  V Agarwal; P Sitholey; S Kumar; M Prasad
Journal:  Ment Retard       Date:  2001-08

Review 2.  Clonidine extended-release: in attention-deficit hyperactivity disorder.

Authors:  Jamie D Croxtall
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

3.  Pharmacokinetics and side-effects of clonidine.

Authors:  A Keränen; S Nykänen; J Taskinen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

Review 4.  The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

Authors:  Floyd R Sallee
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

5.  Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.

Authors:  Scott H Kollins; Rakesh Jain; Matthew Brams; Scott Segal; Robert L Findling; Sharon B Wigal; Moise Khayrallah
Journal:  Pediatrics       Date:  2011-05-09       Impact factor: 7.124

6.  Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.

Authors:  Rakesh Jain; Scott Segal; Scott H Kollins; Moise Khayrallah
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-02       Impact factor: 8.829

7.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

Review 8.  Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Authors:  Sharon B Wigal
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

Authors: 
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

10.  Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.

Authors:  W Burleson Daviss; Nick C Patel; Adelaide S Robb; Michael P McDERMOTT; Oscar G Bukstein; William E Pelham; Donna Palumbo; Peter Harris; Floyd R Sallee
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-02       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.